Title:
RADIOACTIVE PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2024/090488
Kind Code:
A1
Abstract:
The present invention pertains to a liquid pharmaceutical composition that contains, as an active ingredient, a complex of a radioactive isotope and an antibody. The pharmaceutical composition is characterized in that: the antibody specifically binds to mucin subtype 5AC; the concentration of the antibody in the composition is 0.1-5 mg/mL; and the composition contains L-arginine, L-histidine, and a surfactant. The pharmaceutical composition reduces adsorption of radioactivity to a storage container.
Inventors:
TAKEMORI HIDEAKI (JP)
OKUMURA YUKI (JP)
TAKENAKA FUMIAKI (JP)
TONOYA GOTA (JP)
KAWAMURA ERIKO (JP)
HORIUCHI SHOHEI (JP)
OKUMURA YUKI (JP)
TAKENAKA FUMIAKI (JP)
TONOYA GOTA (JP)
KAWAMURA ERIKO (JP)
HORIUCHI SHOHEI (JP)
Application Number:
PCT/JP2023/038580
Publication Date:
May 02, 2024
Filing Date:
October 25, 2023
Export Citation:
Assignee:
NIHON MEDIPHYSICS CO LTD (JP)
SUMITOMO PHARMA CO LTD (JP)
SUMITOMO PHARMA CO LTD (JP)
International Classes:
A61K47/68; A61K9/08; A61K39/395; A61K47/18; A61K47/26; A61K51/10; A61P35/00; C07K16/18
Domestic Patent References:
WO2021075544A1 | 2021-04-22 |
Foreign References:
JP2019206559A | 2019-12-05 | |||
JP2018030879A | 2018-03-01 | |||
JP2012519706A | 2012-08-30 |
Attorney, Agent or Firm:
KAMADA, Mitsunori et al. (JP)
Download PDF:
Previous Patent: DROPLET EJECTION HEAD AND DROPLET EJECTION DEVICE
Next Patent: METHOD FOR PRODUCING RADIOACTIVE PHARMACEUTICAL COMPOSITION
Next Patent: METHOD FOR PRODUCING RADIOACTIVE PHARMACEUTICAL COMPOSITION